19 citations,
December 2016 in “The journal of pharmacology and experimental therapeutics/The Journal of pharmacology and experimental therapeutics” Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.
7 citations,
December 2020 in “Clinical and Experimental Dermatology” Cepharanthine (CEP), a compound derived from Stephania cephalantha, was studied for its effects on hair growth, particularly focusing on human dermal papilla cells (hDPCs). The study found that CEP and two of its structural analogues significantly promoted the proliferation of hDPCs and increased the expression of vascular endothelial growth factor (VEGF) in these cells. This effect was linked to increased intracellular calcium mobilization and activation of hypoxia-inducible factors (HIF-1α and HIF-2α), even under normal oxygen conditions. These findings suggested that CEP and its analogues could potentially aid in hair growth by enhancing hDPC proliferation and VEGF expression.
77 citations,
September 2017 in “Journal of Investigative Dermatology” TRPV3 in skin cells causes inflammation and cell death.
23 citations,
March 2019 in “The journal of investigative dermatology/Journal of investigative dermatology” ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.
119 citations,
July 2016 in “Annals of the New York Academy of Sciences” Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.